Email
Print
1. Facial Injectable Market Overview
2. Facial Injectable Market Executive Summary
3. Facial Injectable Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. Patent Analysis
3.2.3. End User Profiling
4. Facial Injectable Market Forces
4.1. Market Drivers
4.2. Market Constraints/Challenges
5. Facial Injectable Market Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Lifecycle Analysis
6. Facial Injectable Market - By Type
6.1. Introduction
6.2. Dermal Fillers
6.2.1. Synthetic
6.2.1.1. Poly-L-lactic acid
6.2.1.2. Polymethyl-methacrylate microspheres (PMMA)
6.2.1.3. Polyalkylimide
6.2.1.4. Calcium hydroxylapatite
6.2.2. Natural
6.2.2.1. Collagen
6.2.2.1.1. Bovine Collagen
6.2.2.1.2. Porcine Collagen
6.2.2.1.3. Human Collagen
6.2.2.2. Hyaluronic acid
6.3. Botulinum Toxin
6.3.1. Botox
6.3.2. Dysport
6.3.3. Xeonim
6.3.4. Others
7. Facial Injectable Market - By Application
7.1. Introduction
7.2. Lines and Wrinkles Treatment
7.3. Cheek and Chin Augmentation
7.4. Tear Trough Correction
7.5. Nose Re-shaping
7.6. Scar Revision
7.7. Lip enhancement
7.8. Hand Rejuvenation
7.9. Facial Asymmetry
7.10. Others
8. Facial Injectable Market - By End User
8.1. Introduction
8.2. Hospitals
8.3. Dermatology Clinics
8.4. Cosmetic Clinics
8.5. Research and Development Facilities
8.6. Others
9. Facial Injectable Market - By Geography
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Peru
9.3.4. Rest of South America
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. Italy
9.4.4. France
9.4.5. Spain
9.4.6. Russia
9.4.7. Rest of Europe
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. Australia & New Zealand
9.5.5. South Korea
9.5.6. Rest of APAC
9.6. RoW
9.6.1. Middle East
9.6.2. Africa
10. Facial Injectable Market Entropy
11. Facial Injectable Market Company Profiles
11.1. Company 1
11.2. Company 2
11.3. Company 3
11.4. Company 4
11.5. Company 5
11.6. Company 6
11.7. Company 7
11.8. Company 8
11.9. Company 9
11.10. Company 10 and more
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix
12.1. Abbreviations
12.2. Sources
12.3. Research Methodology
12.4. Bibliography
12.5. Compilation of Expert Insights
12.6. Disclaimer